tiprankstipranks
Trending News
More News >
Globus Medical (GMED)
NYSE:GMED
US Market

Globus Medical (GMED) Ratios

Compare
859 Followers

Globus Medical Ratios

GMED's free cash flow for Q1 2025 was $0.67. For the 2025 fiscal year, GMED's free cash flow was decreased by $ and operating cash flow was $0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
6.18 4.88 6.18 6.17 6.80
Quick Ratio
4.30 2.72 4.30 4.48 4.91
Cash Ratio
0.95 1.19 0.95 1.38 1.98
Solvency Ratio
1.12 0.25 1.12 1.01 0.95
Operating Cash Flow Ratio
1.12 0.62 1.12 1.97 1.65
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 753.59M$ 827.25M$ 753.59M$ 648.64M$ 648.58M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.10 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 0.13 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 0.12 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.09 0.00 0.00 0.00
Financial Leverage Ratio
1.12 1.27 1.12 1.12 1.11
Debt Service Coverage Ratio
17.68 0.00 17.68 23.56 11.09
Interest Coverage Ratio
16.02 0.00 16.02 18.50 7.99
Debt to Market Cap
0.00 0.07 0.00 0.00 0.00
Interest Debt Per Share
0.20 4.60 0.20 0.14 0.19
Net Debt to EBITDA
-0.47 0.15 -0.47 -0.75 -1.32
Profitability Margins
Gross Profit Margin
74.22%65.05%74.22%75.03%72.44%
EBIT Margin
23.10%12.87%23.10%18.83%14.63%
EBITDA Margin
29.77%22.10%29.77%26.12%22.60%
Operating Profit Margin
22.29%8.49%22.29%17.95%14.12%
Pretax Profit Margin
23.76%10.54%23.76%18.83%15.96%
Net Profit Margin
18.59%7.83%18.59%15.57%12.96%
Continuous Operations Profit Margin
18.59%7.83%18.59%15.57%12.96%
Net Income Per EBT
78.25%74.29%78.25%82.70%81.24%
EBT Per EBIT
106.61%124.22%106.61%104.92%112.98%
Return on Assets (ROA)
9.16%2.42%9.16%7.62%6.09%
Return on Equity (ROE)
10.30%3.07%10.30%8.57%6.79%
Return on Capital Employed (ROCE)
11.89%2.84%11.89%9.46%7.15%
Return on Invested Capital (ROIC)
9.29%2.10%9.29%7.83%5.81%
Return on Tangible Assets
10.48%4.51%10.48%8.73%7.12%
Earnings Yield
2.55%2.04%2.55%2.05%1.59%
Efficiency Ratios
Receivables Turnover
4.71 3.11 4.71 5.78 5.33
Payables Turnover
7.31 9.67 7.31 10.90 11.95
Inventory Turnover
0.88 0.65 0.88 1.01 0.95
Fixed Asset Turnover
4.20 2.42 4.20 4.33 3.64
Asset Turnover
0.49 0.31 0.49 0.49 0.47
Working Capital Turnover Ratio
1.32 1.34 1.32 1.34 1.24
Cash Conversion Cycle
441.38 644.48 441.38 391.22 422.57
Days of Sales Outstanding
77.55 117.49 77.55 63.11 68.51
Days of Inventory Outstanding
413.79 564.73 413.79 361.61 384.62
Days of Payables Outstanding
49.96 37.73 49.96 33.50 30.56
Operating Cycle
491.34 682.22 491.34 424.72 453.13
Cash Flow Ratios
Operating Cash Flow Per Share
1.78 2.15 1.78 2.74 2.02
Free Cash Flow Per Share
1.04 1.46 1.04 2.18 1.37
CapEx Per Share
0.74 0.69 0.74 0.56 0.65
Free Cash Flow to Operating Cash Flow
0.59 0.68 0.59 0.79 0.68
Dividend Paid and CapEx Coverage Ratio
2.41 3.11 2.41 4.86 3.12
Capital Expenditure Coverage Ratio
2.41 3.11 2.41 4.86 3.12
Operating Cash Flow Coverage Ratio
29.69 0.47 29.69 54.68 41.41
Operating Cash Flow to Sales Ratio
0.17 0.16 0.17 0.29 0.25
Free Cash Flow Yield
1.40%2.74%1.40%3.02%2.10%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
39.24 49.05 39.24 48.75 62.86
Price-to-Sales (P/S) Ratio
7.30 3.84 7.30 7.59 8.15
Price-to-Book (P/B) Ratio
4.04 1.51 4.04 4.18 4.27
Price-to-Free Cash Flow (P/FCF) Ratio
71.46 36.47 71.46 33.15 47.58
Price-to-Operating Cash Flow Ratio
41.81 24.75 41.81 26.33 32.34
Price-to-Earnings Growth (PEG) Ratio
1.42 -1.16 1.42 1.15 -1.86
Price-to-Fair Value
4.04 1.51 4.04 4.18 4.27
Enterprise Value Multiple
24.03 17.54 24.03 28.31 34.73
Enterprise Value
7.32B 6.08B 7.32B 7.08B 6.19B
EV to EBITDA
24.03 17.54 24.03 28.31 34.73
EV to Sales
7.15 3.88 7.15 7.39 7.85
EV to Free Cash Flow
70.08 36.80 70.08 32.30 45.84
EV to Operating Cash Flow
41.00 24.97 41.00 25.64 31.16
Tangible Book Value Per Share
15.78 14.49 15.78 14.82 12.81
Shareholders’ Equity Per Share
18.38 35.35 18.38 17.29 15.28
Tax and Other Ratios
Effective Tax Rate
0.22 0.26 0.22 0.17 0.19
Revenue Per Share
10.18 13.87 10.18 9.51 8.00
Net Income Per Share
1.89 1.09 1.89 1.48 1.04
Tax Burden
0.78 0.74 0.78 0.83 0.81
Interest Burden
1.03 0.82 1.03 1.00 1.09
Research & Development to Revenue
0.07 0.08 0.07 0.10 0.11
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.03 0.03 0.03 0.03 0.03
Income Quality
0.94 1.98 0.94 1.85 1.94
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis